People · Operator
Named in public records as an officer, director or promoter · active 2012–2023 · Other Health Care, Pharmaceuticals, Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| electroCore, Inc. | — | Other Health Care | Series C | $87.3M | $11.0M | 2012 |
| ARS Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $63.0M | $1.3B | 2021 |
| GLO Pharma, Inc. | — | Pharmaceuticals | Series C | $60.4M | $1.2B | 2021 |
| Roam HQ Inc. | — | Other Technology | Series B | $30.0M | $426.4M | 2022 |
| Rapalogix Health, Inc. | — | Biotechnology | Series A | $9.1M | $61.4M | 2023 |
Brent Saunders at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brent Saunders on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Rubin | 1 | 11 |
| Jonathan Leff | 1 | 11 |
| Peter Kolchinsky | 1 | 8 |
| Rajeev Dadoo | 1 | 7 |
| James L.L. Tullis | 1 | 6 |
| Trevor Moody | 1 | 5 |
| David Nicholson | 1 | 5 |
| Pratik Shah | 1 | 5 |
| Jules Maltz | 1 | 5 |
| Scott Glenn | 1 | 4 |
| Lauren Otsuki | 1 | 4 |
| Jeffrey Vinik | 1 | 4 |
| Nicole Quinn | 1 | 4 |
| Howard Lerman | 1 | 3 |
| Thomas Dixon | 1 | 3 |
| James Peyer | 1 | 3 |
| JP Errico | 1 | 2 |
| Trevor J. Moody | 1 | 2 |
| Reese Terry | 1 | 2 |
| Daniel S. Goldberger | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.